CC1(C)O[C@@H]2[C@@H](COS(=O)(=O)[O-])O[C@@H](n3c(S)nc4c(O)nc(N)nc43)[C@@H]2O1.[K+]
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?